Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways

被引:892
作者
Fearon, Kenneth C. H. [1 ]
Glass, David J. [2 ]
Guttridge, Denis C. [3 ]
机构
[1] Univ Edinburgh, Royal Infirm, Sch Clin Sci & Community Hlth, Edinburgh EH16 4SA, Midlothian, Scotland
[2] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[3] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
关键词
SKELETAL-MUSCLE ATROPHY; TUMOR-NECROSIS-FACTOR; ACUTE-PHASE RESPONSE; UBIQUITIN LIGASE ATROGIN1/MAFBX; ADIPOSE TRIGLYCERIDE LIPASE; PROTEOLYSIS INDUCING FACTOR; FOXO TRANSCRIPTION FACTORS; SYNTHASE KINASE 3-BETA; MESSENGER-RNA LEVELS; KAPPA-B ACTIVATION;
D O I
10.1016/j.cmet.2012.06.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cancer cachexia is characterized by a significant reduction in body weight resulting predominantly from loss of adipose tissue and skeletal muscle. Cachexia causes reduced cancer treatment tolerance and reduced quality and length of life, and remains an unmet medical need. Therapeutic progress has been impeded, in part, by the marked heterogeneity of mediators, signaling, and metabolic pathways both within and between model systems and the clinical syndrome. Recent progress in understanding conserved, molecular mechanisms of skeletal muscle atrophy/hypertrophy has provided a downstream platform for circumventing the variations and redundancy in upstream mediators and may ultimately translate into new targeted therapies.
引用
收藏
页码:153 / 166
页数:14
相关论文
共 179 条
  • [11] Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
    Baracos, Vickie E.
    Reiman, Tony
    Mourtzakis, Marina
    Gioulbasanis, Ioannis
    Antoun, Sami
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (04) : 1133S - 1137S
  • [12] A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
    Bayliss, Trevor J.
    Smith, Jeff T.
    Schuster, Michael
    Dragnev, Konstantin H.
    Rigas, James R.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (12) : 1663 - 1668
  • [13] Effect of cancer cachexia on triacylglycerol/fatty acid substrate cycling in white adipose tissue
    Beck, SA
    Tisdale, MJ
    [J]. LIPIDS, 2004, 39 (12) : 1187 - 1189
  • [14] Animal models of the cancer anorexia-cachexia syndrome
    Bennani-Baiti, Nabila
    Walsh, Declan
    [J]. SUPPORTIVE CARE IN CANCER, 2011, 19 (09) : 1451 - 1463
  • [15] Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy
    Bentzinger, C. Florian
    Romanino, Klaas
    Cloetta, Dimitri
    Lin, Shuo
    Mascarenhas, Joseph B.
    Oliveri, Filippo
    Xia, Jinyu
    Casanova, Emilio
    Costa, Celine F.
    Brink, Marijke
    Zorzato, Francesco
    Hall, Michael N.
    Rueegg, Markus A.
    [J]. CELL METABOLISM, 2008, 8 (05) : 411 - 424
  • [16] CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN
    BEUTLER, B
    CERAMI, A
    [J]. NATURE, 1986, 320 (6063) : 584 - 588
  • [17] Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia
    Bing, C
    Bao, Y
    Jenkins, J
    Sanders, P
    Manieri, M
    Cinti, S
    Tisdale, MJ
    Trayhurn, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (08) : 2500 - 2505
  • [18] CHINESE-HAMSTER OVARIAN-CELLS TRANSFECTED WITH THE MURINE INTERLEUKIN-6 GENE CAUSE HYPERCALCEMIA AS WELL AS CACHEXIA, LEUKOCYTOSIS AND THROMBOCYTOSIS IN TUMOR-BEARING NUDE-MICE
    BLACK, K
    GARRETT, IR
    MUNDY, GR
    [J]. ENDOCRINOLOGY, 1991, 128 (05) : 2657 - 2659
  • [19] Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise
    Bodell, P. W.
    Kodesh, E.
    Haddad, F.
    Zaldivar, F. P.
    Cooper, D. M.
    Adams, G. R.
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2009, 106 (02) : 443 - 453
  • [20] Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
    Bodine, SC
    Stitt, TN
    Gonzalez, M
    Kline, WO
    Stover, GL
    Bauerlein, R
    Zlotchenko, E
    Scrimgeour, A
    Lawrence, JC
    Glass, DJ
    Yancopoulos, GD
    [J]. NATURE CELL BIOLOGY, 2001, 3 (11) : 1014 - 1019